AKAMIS BIO LIMITED – Trademark Portfolio
Entity Type: 99
AKAMIS BIO LIMITED holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AKAMIS, T-SIGN, and AKAMIS BIO. The owner is based in ABINGDON, OXFORDSHIRE.
AKAMIS HOUSE, 4-10 THE QUADRANT
ABINGDON SCIENCE PARK, BARTON LANE
ABINGDON, OXFORDSHIRE OX143YS , GB
Showing of trademarks Trademarks
Trademark Classifications
AKAMIS BIO LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does AKAMIS BIO LIMITED have?
AKAMIS BIO LIMITED has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 cancelled.
What trademark classes does AKAMIS BIO LIMITED file in?
AKAMIS BIO LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are AKAMIS BIO LIMITED's most well-known trademarks?
AKAMIS BIO LIMITED's registered trademark portfolio includes well-known marks such as AKAMIS, T-SIGN, and AKAMIS BIO. These are among 4 currently registered trademarks in the portfolio.
What is AKAMIS BIO LIMITED's trademark registration success rate?
AKAMIS BIO LIMITED has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.